Alimera Sciences (NASDAQ:ALIM – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Friday. Separately, Maxim Group initiated coverage on Alimera Sciences in a research note on Monday, March 25th. They set a “buy” rating and a $10.00 price objective on the […]